Thi N. Huynh
Yuseong, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway.
Journal: Antioxidants (Basel, Switzerland)
Published: March 02, 2022
Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway.
Journal: Archives of pharmacal research
Published: January 12, 2022
Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis.
Journal: Archives of pharmacal research
Published: September 30, 2021
Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells.
Journal: International journal of molecular sciences
Published: May 06, 2021
Ginsenoside-Rg2 affects cell growth via regulating ROS-mediated AMPK activation and cell cycle in MCF-7 cells.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 19, 2020
Protective effects of ginsenoside-Rg2 and -Rh1 on liver function through inhibiting TAK1 and STAT3-mediated inflammatory activity and Nrf2/ARE-mediated antioxidant signaling pathway.
Journal: Archives of pharmacal research
Published: November 24, 2020
Minor Ginsenoside Rg2 and Rh1 Attenuates LPS-Induced Acute Liver and Kidney Damages via Downregulating Activation of TLR4-STAT1 and Inflammatory Cytokine Production in Macrophages.
Journal: International journal of molecular sciences
Published: July 23, 2020
Therapeutic effects of ginsenosides on breast cancer growth and metastasis.
Journal: Archives of pharmacal research
Published: June 26, 2020
Inhibition of p90RSK is critical to abolish Angiotensin II-induced rat aortic smooth muscle cell proliferation and migration.
Journal: Biochemical and biophysical research communications
Published: November 23, 2019
Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT.
Journal: BMB reports
Published: September 26, 2019
Therapeutic targets for endothelial dysfunction in vascular diseases.
Journal: Archives of pharmacal research
Published: July 09, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026